Synopsis: This study evaluates the potential for a novel genetic classifier in patients with pulmonary nodules to increase the sensitivity and specificity of lung cancer screening and thereby reduce the number of patients being exposed to the harms of invasive diagnostic testing.
Source: Vachani A, Whitney D, Parsons E, et al. Clinical utility of a bronchial genomic classifier in patients with suspected lung cancer. Chest. 2016;150(1):210–218.